Skip to main content
. 2019 Feb 25;106(5):596–605. doi: 10.1002/bjs.11094

Table 2.

Diagnostic performance for assessment of residual tumour

T2W‐MRI T2W + DW‐MRI
Reader 1 Reader 2 Reader 3 Reader 1 Reader 2 Reader3
Sensitivity (%) 100 90 90 95 97 90
(89, 100) (75, 97) (75, 97) (81, 99) (85, 100) (75, 97)
Specificity (%) 8 25 25 50 42 42
(0, 40) (7, 57) (7, 57) (22, 78) (17, 71) (17, 71)
PPV (%) 78 80 80 86 84 83
(64, 88) (64, 90) (64, 90) (71, 94) (70, 93) (68, 92)
NPV (%) 100 43 43 75 83 56
(6, 100) (12, 80) (12, 80) (36, 96) (37, 99) (23, 85)
True‐positive 39 35 35 37 38 35
False‐positive 11 9 9 6 7 7
True‐negative 1 3 3 6 5 5
False‐negative 0 4 4 2 1 4
Accuracy (%) 78 75 75 84 84 78
AUC* 0·65 0·66 0·68 0·71 0·70 0·70
(0·47, 0·83) (0·49, 0·83) (0·51, 0·86) (0·52, 0·90) (0·52, 0·88) (0·51, 0·88)

Values in parentheses are 95 per cent confidence intervals. Residual tumour (tumour regression grade 2–5 in resected primary tumour) was considered the positive outcome. T2W, T2‐weighted; DW, diffusion‐weighted; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the receiver operating characteristic curve.

*

Comparison of T2W‐MRI versus T2W + DW‐MRI: P = 0·441, P = 0·611 and P = 0·828 for readers 1, 2 and 3 respectively (DeLong test33).